IMSD at the University of Rochester
IMSD at the University of Rochester
批准号:
10552964
负责人:
CRAIG N MORRELL
金额:
$16.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-01 至 2028-01-31
关键词:
中文摘要
项目概要:罗切斯特中心的主要目标:教育和提高聋人/重聋者
听力研究生,(THREADgS)是严格培养聋人和重听(D/HH)博士前
学者和支持他们进入生物医学研究企业的独立学术生涯的进步。
这是一个重要的未满足的国家需求:D/HH社区在生物医学科学中的代表性严重不足
学术劳动力。即便如此,美国任何一所研究型大学都没有T32项目,
重点培养D/HH研究生。罗切斯特大学(UR)和罗切斯特社区
作为一个整体,有资源和基础设施,以支持D/HH学习者在所有其他职业阶段。作为UR
扩大对D/HH学习者的支持,THREADgS还将促进基础设施的进一步发展,
支持美国手语(ASL)翻译培训科学术语,通过集中的
机制它将改善D/HH科学家的环境,通过“指导导师”积极维护
D/HH学员的包容性沟通战略。此外,通过自由传播我们的方法和成果,
该提案的成功实施将改善各地D/HH STEM研究生的培训。
我们的目标是:1)URSMD的D/HH研究生学者数量在五年内翻了一番,NIH类别B
人口统计学-残疾人-在生物医学研究中严重不足。2.)
完成我们的NIGMS资助的生物医学研究D/HH培训管道,目前支持
本科生、硕士生和博士生。研究员,但不是研究生学者。这是唯一的职业管道
D/HH个人在任何研究密集型机构。3.)第三章显著改善聋人意识指导
通过正规培训的机构支持。4.)促进保留,社会凝聚力,并确定为
D/HH研究生学者中的生物医学研究人员,以提高毕业率,减少培训时间。5.)
通过促进建立技术词汇,改善D/HH所有生物医学研究人员的科学培训
美国手语(ASL)的手语,并通过自由传播我们作为同行的方法和成果,
评论文章我们将每年招聘3名新的D/HH学者,最多任期为三年,
T32资助,以保持该计划内9名D/HH学者的稳定状态。随着学员离开T32资金
并完成他们的研究生学业,他们将建立一个更大的D/HH学者社区。总体而言,这款独特的T32
该计划将使我们的学者具备成功职业所需的知识和研究技能
进步。我们的最终目标是,我们的学者将实现全职学术任命在更高的
教育和/或研究机构,以减少D/HH教师服务于国家的生物医学缺乏
研究需要。
英文摘要
Project Summary: The primary objective of The Hub at Rochester: Educating and Advancing Deaf/hard of
hearing graduate Students, (THREADgS) is to rigorously train deaf and hard of hearing (D/HH) pre-doctoral
Scholars and support their advance into independent academic careers within biomedical research enterprise.
This is a vital unmet national need: the D/HH community is greatly underrepresented in the biomedical science
academic workforce. Even so, there is no T32 program at any United States research-intensive university that
focuses on training D/HH graduate students. The University of Rochester (UR) and the Rochester community
as a whole have the resources and infrastructure to support D/HH learners at all other career stages. As the UR
expands support for D/HH learners, THREADgS will also stimulate the further development of infrastructure to
support American Sign Language (ASL) interpreter training in scientific terminology through a centralized
mechanism. It will improve the environment for D/HH scientists, by “mentoring the mentors” to actively maintain
inclusive communication strategies for D/HH trainees. Also, by freely disseminating our approach and outcomes,
a successful implementation of this proposal will improve training for D/HH STEM graduate students everywhere.
Our goals are: 1.) Double the number of D/HH graduate Scholars at URSMD in five years, an NIH Category B
demographic – individuals with disabilities – that are critically underrepresented in biomedical research. 2.)
Complete our NIGMS-funded pipeline for D/HH training in biomedical research, which currently supports
undergraduates, masters’ students, and Ph.D. fellows, but not graduate Scholars. This is the only career pipeline
for D/HH individuals at any research-intensive institution. 3.) Dramatically improve Deaf-aware mentoring
through institutional support of formal training. 4.) Promote retention, social cohesion, and identification as
biomedical researchers among D/HH graduate Scholars to improve graduate rates and reduce training time. 5.)
Improve scientific training for all D/HH biomedical researchers by contributing to established lexicons of technical
signs in American Sign Language (ASL) and by freely disseminating both our approach and outcomes as peer-
reviewed articles. We will recruit 3 new D/HH scholars per year, with a maximum of a three-year appointment in
T32 funding, to maintain a steady state of 9 D/HH Scholars within the program. As trainees leave T32 funding
and complete their graduate studies, they will build a larger D/HH scholar community. Overall, this unique T32
program will equip our Scholars with the knowledge and research skills necessary for successful career
advancement. The ultimate goal is that our Scholars will achieve full-time academic appointments in higher
education and/or research institutions to reduce the dearth of D/HH faculty serving the nation's biomedical
research needs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tissue Dependent Megakaryocyte Functions
-
批准号:10337469
-
项目类别:
-
资助金额:$50.91万
-
财政年份:2022
-
负责人:CRAIG N MORRELL
-
依托单位:
Tissue Dependent Megakaryocyte Functions
-
批准号:10569096
-
项目类别:
-
资助金额:$50.91万
-
财政年份:2022
-
负责人:CRAIG N MORRELL
-
依托单位:
Platelet-Regulated Immune Responses in Neonates Following Transfusion
-
批准号:10217253
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2020
-
负责人:CRAIG N MORRELL
-
依托单位:
Platelet-Regulated Immune Responses in Neonates Following Transfusion
-
批准号:10039184
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2020
-
负责人:CRAIG N MORRELL
-
依托单位:
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injury
-
批准号:10323025
-
项目类别:
-
资助金额:$63.2万
-
财政年份:2019
-
负责人:CRAIG N MORRELL
-
依托单位:
Novel mechanisms of platelet modified monocyte phenotype
-
批准号:10166903
-
项目类别:
-
资助金额:$46.44万
-
财政年份:2018
-
负责人:CRAIG N MORRELL
-
依托单位:
Novel mechanisms of platelet modified monocyte phenotype
-
批准号:10377113
-
项目类别:
-
资助金额:$36.45万
-
财政年份:2018
-
负责人:CRAIG N MORRELL
-
依托单位:
Novel platelet functions for in T-cell helper cell responses
-
批准号:9385749
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2014
-
负责人:CRAIG N MORRELL
-
依托单位:
Novel platelet functions for in T-cell helper cell responses
-
批准号:8967578
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2014
-
负责人:CRAIG N MORRELL
-
依托单位:
Novel platelet functions for in T-cell helper cell responses
-
批准号:8814885
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2014
-
负责人:CRAIG N MORRELL
-
依托单位:
Glutamate Mediates Platelet Activation through an Ionotropic Glutamate Receptor
-
批准号:7729367
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2009
-
负责人:CRAIG N MORRELL
-
依托单位:
Glutamate Mediates Platelet Activation through an Ionotropic Glutamate Receptor
-
批准号:8065694
-
项目类别:
-
资助金额:$38.29万
-
财政年份:2009
-
负责人:CRAIG N MORRELL
-
依托单位:
Glutamate Mediates Platelet Activation through an Ionotropic Glutamate Receptor
-
批准号:8067125
-
项目类别:
-
资助金额:$38.56万
-
财政年份:2009
-
负责人:CRAIG N MORRELL
-
依托单位:
Glutamate Mediates Platelet Activation through an Ionotropic Glutamate Receptor
-
批准号:8255473
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2009
-
负责人:CRAIG N MORRELL
-
依托单位:
The Role of Platelets in Alloantibody Mediated Transplant Rejection
-
批准号:7903573
-
项目类别:
-
资助金额:$26.14万
-
财政年份:2009
-
负责人:CRAIG N MORRELL
-
依托单位:
The Role of Platelets in Alloantibody Mediated Transplant Rejection
-
批准号:8311665
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2008
-
负责人:CRAIG N MORRELL
-
依托单位:
The Role of Platelets in Alloantibody Mediated Transplant Rejection
-
批准号:8121469
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2008
-
负责人:CRAIG N MORRELL
-
依托单位:
The Role of Platelets in Alloantibody Mediated Transplant Rejection
-
批准号:7662580
-
项目类别:
-
资助金额:$38.48万
-
财政年份:2008
-
负责人:CRAIG N MORRELL
-
依托单位:
The Role of Platelets in Alloantibody Mediated Transplant Rejection
-
批准号:7904222
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2008
-
负责人:CRAIG N MORRELL
-
依托单位:
Nitric Oxide Regulation of Platelet Granule Exocytosis
-
批准号:6704321
-
项目类别:
-
资助金额:$8.53万
-
财政年份:2003
-
负责人:CRAIG N MORRELL
-
依托单位:
海外基金